STRO vs WTW · rev $62.0M vs P/E 15, rev $9.93B
Sutro Biopharma (STRO) versus Willis Towers Watson PLC (WTW) — a side-by-side from cached financials, not a winner call.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Willis Towers Watson PLC (WTW) is a insurance brokers company listed on NASDAQ.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
Latest reported WTW revenue for 2024-12-31 was $9.93B. Net income was -$88.0M. Revenue was up 4.7% from 2023-12-31 to 2024-12-31. WTW currently screens at market cap $24.41B and trailing P/E 15.2.
STRO currently screens at market cap $470.8M. WTW currently screens at market cap $24.41B and trailing P/E 15.2.
Not investment advice. Open the STRO and WTW stock pages for the full models.
Not investment advice.